Dr Sharon Van Doornum

		Qualifications:		MBBS, Grad Dip Clin Epi, MD, FRACP
		Position:		Senior Lecturer
		Location:		University of Melbourne Dept of Medicine
		Postal Address:		The University of Melbourne Department of Medicine (RMH/WH) Royal Melbourne Hospital 4th Floor Clinical Sciences Building Parkville, Melbourne, Victoria, Australia 3050
		Telephone:		+61-3 8344 3144
		Fax:		+61-3 9342 7632
		Email:		svd@unimelb.edu.au

Biography

Dr Van Doornum is a clinician-researcher who studied medicine at The University of Melbourne and undertook clinical training at The Royal Melbourne Hospital. After completing basic physician training she completed specialty training in the field of Rheumatology and also completed a Graduate Diploma in Clinical Epidemiology (Monash). Dr Van Doornum was awarded an NHMRC Post Graduate Scholarship to undertake a Doctorate of Medicine at The University of Melbourne.  Upon completion of her doctorate, Dr Van Doornum was appointed senior lecturer in The University of Melbourne Department of Medicine (RMH/WH).  Dr Van Doornum divides her time between clinical research and public hospital service as a consultant rheumatologist at The Royal Melbourne Hospital.

Dr Van Doornum has been awarded a number of fellowships and grants for her research from organizations including the Victor Hurley Research Trust (2000), CVL Pfizer Research Fund (2001), The Arthritis Foundation of Australia (2001, 2004, 2006),The Heart Foundation (2005) and The Royal Australian College of Physicians (2004, 2007).  Dr Van Doornum has also been awarded a number of traveling fellowships including a Preceptorship in Advanced Rheumatology (Boston 2002) and the Melbourne-Boston Exchange Fellowship (2005).

Dr Van Doornum’s research has published in international peer-reviewed journals and she has been an invited speaker at Australian and international rheumatology conferences. She has reviewed manuscripts for several international journals, and has been an assessor for the NHMRC Project Grants scheme.

Research Interests

Publications

• Van Doornum S, Brand C, Ajani A, Sundararajan V and Wicks I. Early management of myocardial infarction in RA patients - a comparison with the general population. Internal Medicine Journal 2008; 38(Suppl. 2): A24
• Van Doornum S, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. .Arthritis Rheum 2006;54(7):2061-8
• Van Doornum S, Jennings G, Wicks I. Reducing the Cardiovascular Burden in Rheumatoid Arthritis. Med J Aust 2006;184:287-90
• Van Doornum S, McColl G, Wicks IP.  TNF Antagonists Improve Disease Activity But Not Arterial Stiffness in RA. Rheumatology (Oxford). 2005;44:1428-32
• Van Doornum S, King B, Brand C. Screening and management of cardiovascular risk factors (CVRFs) in RA patients.. Internal Medicine Journal. 35(11):A115, 2005.
• Reed D.M, Moran H, McColl G, Stockman A, Barraclough D, Van Doornum S, Brand, C, Roberts J.L. Time to institution of DMARD therapy in Victoria - an early RA pilot study. Internal Medicine Journal. 35(11):A112, 2005.
• Van Doornum S, McColl G, Wicks IP. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 2004;63:1571-1575.
• Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP. Screening For Atherosclerosis In Rheumatoid Arthritis: Comparison Of Two In-Vivo Tests Of Vascular Function.  Arthritis Rheum 2003;48:72-80.
• Van Doornum S, McColl G, Wicks IP.  Accelerated atherosclerosis:an extra-articular feature of rheumatoid arthritis?  Arthritis Rheum 2002;46:862-873.
• Van Doornum S, McColl G, Walter M, Jennens I, Bhathal P, Wicks IP.  Prolonged prodrome, systemic vasculitis and deafness in Cogan’s syndrome.  Ann Rheum Dis 2001;60:69-71.
• Van Doornum S, Barraclough D, McColl G, Wicks IP.  SAPHO: Rare, or just not recognized?  Semin Arthritis Rheum 2000;30:70-77.
• Van Doornum S, Ryan PFJ.  Clinical manifestations of gout and their management.  Med J Aust 2000;172:493-497.